Evidence map›Paper›PMID 28095098›Full record

ArticleOphthalmic genetics

Reduced penetrance in a large Caucasian pedigree with Stickler syndrome.

Stuart W Tompson, Charles Johnson, Diana Abbott, Benjamin Bakall, Vincent Soler, Tammy L Yanovitch, Kristina N Whisenhunt, Thomas Klemm, Steve Rozen, Edwin M Stone and 2 more

Abstract read
In one paragraph

Article in Ophthalmic genetics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Pathogenicity effects of aTranslational pediatrics · 2025
    Article
  2. A novelFrontiers in genetics · 2025
    Article
  3. Pregnancy management in a patient with stickler syndrome.Molecular genetics & genomic medicine · 2020
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 3 countries.

Stuart W Tompsona Department of Ophthalmology and Visual Sciences , University of Wisconsin - Madison , Madison , Wisconsin , USA.
Charles Johnsonb Retina Consultants, Ltd ., Fargo , North Dakota , USA.
Diana Abbottc Department of Biostatistics and Informatics , University of Colorado Anschutz Medical Campus , Aurora , Colorado , USA.
Benjamin Bakalld Department of Ophthalmology and Visual Sciences , University of Iowa Carver College of Medicine , Iowa City , Iowa , USA.
Vincent Solere Centre de Physiopathologie de Toulouse Purpan , Université Paul Sabatier , Toulouse , France.
Tammy L Yanovitchf Department of Ophthalmology, Dean McGee Eye Institute , University of Oklahoma , Oklahoma City , Oklahoma , USA.
Kristina N Whisenhunta Department of Ophthalmology and Visual Sciences , University of Wisconsin - Madison , Madison , Wisconsin , USA.
Thomas Klemmg Duke-National University of Singapore Graduate Medical School , Singapore.
Steve Rozeng Duke-National University of Singapore Graduate Medical School , Singapore.
Edwin M Stoned Department of Ophthalmology and Visual Sciences , University of Iowa Carver College of Medicine , Iowa City , Iowa , USA.
Max Johnsonb Retina Consultants, Ltd ., Fargo , North Dakota , USA.
Terri L Younga Department of Ophthalmology and Visual Sciences , University of Wisconsin - Madison , Madison , Wisconsin , USA.
University of Wisconsin–Madison · USCalifornia Retina Consultants · USNational University of Singapore · SGUniversity of Iowa · USUniversité Toulouse III - Paul Sabatier · FRUniversity of Colorado Anschutz Medical Campus · USUniversity of Oklahoma · US

Funding

The Molecular Genetics of High MyopiaR01EY014685 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI YOUNG, TERRI LOIS · 2003 to 2017
$8.1M
NEI NIH HHS R01 EY014685
6 · The paper itself

Abstract

backgroundIn a four-generation Caucasian family variably diagnosed with autosomal dominant (AD) Stickler or Wagner disease, commercial gene screening failed to identify a mutation in COL2A1 or VCAN. We utilized linkage mapping and exome sequencing to identify the causal variant. MATERIALS AND

methodsGenomic DNA samples collected from 40 family members were analyzed. A whole-genome linkage scan was performed using Illumina HumanLinkage-24 BeadChip followed by two-point and multipoint linkage analyses using FASTLINK and MERLIN. Exome sequencing was performed on two affected individuals, followed by co-segregation analysis.

resultsParametric multipoint linkage analysis using an AD inheritance model demonstrated HLOD scores > 2.00 at chromosomes 1p36.13-1p36.11 and 12q12-12q14.1. SIMWALK multipoint analysis replicated the peak in chromosome 12q (peak LOD = 1.975). FASTLINK two-point analysis highlighted several clustered chromosome 12q SNPs with HLOD > 1.0. Exome sequencing revealed a novel nonsense mutation (c.115C>T, p.Gln39*) in exon 2 of COL2A1 that is expected to result in nonsense-mediated decay of the RNA transcript. This mutation co-segregated with all clinically affected individuals and seven individuals who were clinically unaffected.

conclusionsThe utility of combining traditional linkage mapping and exome sequencing is highlighted to identify gene mutations in large families displaying a Mendelian inheritance of disease. Historically, nonsense mutations in exon 2 of COL2A1 have been reported to cause a fully penetrant ocular-only Stickler phenotype with few or no systemic manifestations. We report a novel nonsense mutation in exon 2 of COL2A1 that displays incomplete penetrance and/or variable age of onset with extraocular manifestations.

Indexed as

Codon, NonsensePenetranceAdultAgedArthritisChildChromosome MappingCollagen Type IIConnective Tissue DiseasesDNA Mutational AnalysisExomeFemaleGenetic LinkageGenetic TestingHearing Loss, SensorineuralHumansCodon, NonsenseCOL2A1 protein, humanCollagen Type IILinkagepenetranceStickler syndromeWagner syndrome

Identifiers

PMID28095098
PMCPMC6680000
OpenAlexW2572082510

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.